Kolexia
Oules-Guieu Valerie
Médecine générale
Centre D'imagerie Monticelli Velodrome
Marseille, France
35 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hépatite Hépatite C Hépatite C chronique Carcinome hépatocellulaire Carcinomes Hépatite chronique Fibrose Tumeurs du foie Cirrhose du foie

Industries

Abbvie
12 collaboration(s)
Dernière en 2023
Gilead
9 collaboration(s)
Dernière en 2023
B3TSI
4 collaboration(s)
Dernière en 2021
Tillotts
2 collaboration(s)
Dernière en 2022

Dernières activités

Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching.
World journal of gastrointestinal oncology   28 septembre 2022
Hepatocellular carcinoma macroscopic gross appearance on imaging: predictor of outcome after transarterial chemoembolization in a real-life multicenter French cohort.
European journal of gastroenterology & hepatology   06 octobre 2020
Hepatitis B virus infection: control or cure?.
La Revue du praticien   20 mai 2019
Sorafenib: Experience and Better Manage-ment of Side Effects Improve Overall Survival in Hepatocellular Carcinoma Patients: A Real-Life Retrospective Analysis.
Liver cancer   27 mars 2019
Sofosbuvir, velpatasvir and voxilaprevir: a new triple combination for hepatitis C virus treatment. One pill fits all? Is it the end of the road?
Therapeutic advances in gastroenterology   02 décembre 2018
Hepatocellular carcinoma recurrence in hepatitis C virus-related cirrhosis treated with direct-acting antivirals: a case-control study.
European journal of gastroenterology & hepatology   17 septembre 2018
Impact of direct acting antivirals (DAA) against chronic hepatitis C (HCV) on hepatocellular carcinoma (HCC) recurrence: A case-control study.
Asia Pacific Digestive Week (APDW) Innovative Approaches to Gastroenterology, Kobe, Japan, 2—5 November 2016   19 octobre 2016
Multidisciplinary approach for the treatment of 1155 HCV/HCV-HIV co-infected patients
Abstracts of the 2016 International Symposium on HIV and Emerging Infectious Diseases (ISHEID), 25–27 May 2016, Marseille, France   01 mai 2016
Clinical relevance of the HCV protease inhibitor-resistant mutant viral load assessed by ultra-deep pyrosequencing in treatment failure.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology   26 février 2016
Sofosbuvir plus ledipasvir in combination for the treatment of hepatitis C infection.
Expert review of gastroenterology & hepatology   23 novembre 2015